Omics Profiles of Fecal Microbiota Change in Irritable Bowel Syndrome Patients with Diarrhea and Symptom Exacerbation
Project/Area Number |
17K17584
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
General internal medicine(including psychosomatic medicine)
Gastroenterology
|
Research Institution | Tohoku University |
Principal Investigator |
Tanaka Yukari 東北大学, 医学系研究科, 大学院非常勤講師 (50721453)
|
Project Period (FY) |
2017-04-01 – 2022-03-31
|
Project Status |
Completed (Fiscal Year 2021)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2019: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2018: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2017: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
Keywords | 過敏性腸症候群 / 腸内細菌 / 口腔細菌 / 縦走オミクス / 腸内細菌叢 / 神経伝達物質 / メタボローム解析 / 細菌叢 / ストレス科学 / 下部消化管学 |
Outline of Final Research Achievements |
Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction. However, the role of gastrointestinal microbiota during IBS symptom exacerbation remains unclear. We tested the hypothesis that the fecal microbial composition are altered during the exacerbation of IBS symptoms. Fecal samples were collected from 43 men with IBS with diarrhea (IBS-D) and 40 healthy control (HC) men. Samples in the IBS-D patients were also collected during symptom exacerbation. The composition of the fecal microbiota was determined by analyzing the 16S rRNA gene and metabolites. The fecal microbiota during IBS symptom exacerbation exhibited significant differences in the phylogenic pattern and short-chain fatty acid compared to without symptom exacerbation. Although there were no significant differences in the phylogenic pattern of fecal microbiota abundance between HCs and IBS-D patients.Our findings suggest that fecal microbiome are altered in IBS-D patients during exacerbation of symptoms.
|
Academic Significance and Societal Importance of the Research Achievements |
今回、IBS患者と健常者間、更にIBSの通常排便時と腹部症状出現時比較により、消化管細菌叢のみならず、短鎖脂肪酸や神経伝達物質代謝の変化を明らかにした。これまで申請者らはIBS患者の大腸伸展刺激時の局所脳活動変化を報告してきた。IBSは中枢神経と消化管神経叢間での双方向の情報伝達関連が示唆されるものの、IBSの腹部症状出現タイミングの予測が困難なため研究手法が限られていた。本研究のように侵襲が少ない細菌叢をターゲットとし、同一被験者について複数回の検体採取、並びに縦走オミクス解析を行うことで、今後IBSの症状出現時の消化管環境メカニズムの解明に寄与できる可能性を示すことができた。
|
Report
(6 results)
Research Products
(12 results)
-
-
[Journal Article] Cohort Profile: Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study (TMM BirThree Cohort Study): rationale, progress and perspective.2020
Author(s)
Kuriyama S, Metoki H, Kikuya M, Obara T, Ishikuro M, Yamanaka C, Nagai M, Matsubara H, Kobayashi T, 57名略, Yamamoto M.
-
Journal Title
Int J Epidemiol.
Volume: 49(1)
Issue: 1
Pages: 18-19
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
[Journal Article] Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome.2017
Author(s)
Kano M, Muratsubaki T, Van Oudenhove L, Morishita J, Yoshizawa M, Kohno K, Yagihashi M, Tanaka Y, Mugikura S, Dupont P, Ly HG, Takase K, Kanazawa M, Fukudo S.
-
Journal Title
Sci Rep
Volume: 29
Issue: 1
Pages: 12425-12425
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-